Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
Pyung Chun OhYoung Sil EomJeonggeun MoonHo-Jun JangTae-Hoon KimJon SuhMin Gyu KongSang-Don ParkSung Woo KwonSoon Yong SuhKyounghoon LeeSeung Hwan HanTaehoon AhnWoong Cheol KangPublished in: BMC cardiovascular disorders (2020)
The addition of HLI, dysglycemia, anemia, and high NLR to the TIMI risk score may be useful for very early risk stratification in patients with STEMI receiving primary PCI.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- antiplatelet therapy
- cardiovascular events
- chronic kidney disease
- coronary artery bypass grafting
- clinical practice
- risk factors
- iron deficiency
- atrial fibrillation
- cardiovascular disease
- heart failure
- coronary artery bypass